The purpose of this study was to determine whether both a,-and a,-adrenergic receptors exist on vascular smooth muscle of microvessels and whether adrenergic constriction of anatomically distinct microvascular segments is differentially subserved by either receptor subtype. The cremaster skeletal muscle of anesthetized rats was acutely denervated and suspended in a Krebs bath containing cocaine, normetanephrine, and propranolol to block uptake,, uptake,, and /3-receptors, respectively. Intravital microscopy was used to study large distributing arterioles (mean diameter, 100 ju,m), small precapillary arterioles (25 /xra), and capacitance venules (140 /xm). Concentration-response (diameter change) curves were obtained for bath-added agonists norepinephrine (mixed aja 2 ), phenylephrine (a,), and B-HT 933 (a,) in the absence or presence of antagonists prazosin (a,) and yohimbine (a,). Apparent pD 2 ( -log EDg,) values for large arterioles and venules were, respectively, as follows: norepinephrine (7.41 and 7.15), phenylephrine (5.95 and 5.41), and B-HT 933 (5.05 and 5.06). Low concentrations of prazosin (10~8 M) and yohimbine (10" 7 M) produced receptor subtype-selective antagonism and parallel, dextral displacement of norepinephrine curves for large arterioles and venules. The large arteriole pK B ( -log K B ) was 7.83 ±0.65 for prazosin and 7.36 ±0.46 for yohimbine. Higher concentrations of prazosin (10~7 and 3 x 10~7 M) and yohimbine (10~6 M) produced further dextral but nonparallel displacement of norepinephrine curves. In contrast, receptor subtype-selective concentrations of only yohimbine inhibited adrenergic constriction of small, precapillary arterioles; but prazosin had no effect at receptor subtype-selective concentrations. These data suggest that adrenergic regulation of large arterioles and venules in skeletal muscle uses both a,-and a,-adrenoceptors. Precapillary arterioles, however, may be subserved predominantly by a 2 -receptors.
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The purpose of this study was to determine whether both a,-and a,-adrenergic receptors exist on vascular smooth muscle of microvessels and whether adrenergic constriction of anatomically distinct microvascular segments is differentially subserved by either receptor subtype. The cremaster skeletal muscle of anesthetized rats was acutely denervated and suspended in a Krebs bath containing cocaine, normetanephrine, and propranolol to block uptake,, uptake,, and /3-receptors, respectively. Intravital microscopy was used to study large distributing arterioles (mean diameter, 100 ju,m), small precapillary arterioles (25 /xra), and capacitance venules (140 /xm). Concentration-response (diameter change) curves were obtained for bath-added agonists norepinephrine (mixed aja 2 ), phenylephrine (a,), and B-HT 933 (a,) in the absence or presence of antagonists prazosin (a,) and yohimbine (a,). Apparent pD 2 ( -log EDg,) values for large arterioles and venules were, respectively, as follows: norepinephrine (7.41 and 7.15), phenylephrine (5.95 and 5.41), and B-HT 933 (5.05 and 5.06). Low concentrations of prazosin (10~8 M) and yohimbine (10" 7 M) produced receptor subtype-selective antagonism and parallel, dextral displacement of norepinephrine curves for large arterioles and venules. The large arteriole pK B ( -log K B ) was 7.83 ±0.65 for prazosin and 7.36 ±0.46 for yohimbine. Higher concentrations of prazosin (10~7 and 3 x 10~7 M) and yohimbine (10~6 M) produced further dextral but nonparallel displacement of norepinephrine curves. In contrast, receptor subtype-selective concentrations of only yohimbine inhibited adrenergic constriction of small, precapillary arterioles; but prazosin had no effect at receptor subtype-selective concentrations. These data suggest that adrenergic regulation of large arterioles and venules in skeletal muscle uses both a,-and a,-adrenoceptors. Precapillary arterioles, however, may be subserved predominantly by a 2 -receptors. (Circulation Research 1988; 62:37-50) T he microcirculation is composed of several functionally distinct vessel segments arranged in series (e.g., large distributing arterioles, small precapillary arterioles, capillaries, and capacitance venules).
1 -2 Much of our knowledge concerning the neural control of these segments extends indirectly from pressure-flow studies of whole organs and whole animal studies. Recently, with the use of in situ microcirculatory techniques, it has become evident that both the distribution of adrenergic nerves and the neurogenic response patterns of the different microvascular levels exhibit clear differences.'" 3 However, the underlying mechanisms and functional significanceof these differences remain incompletely understood. Knowledge concerning the type and distribution of adrenergic receptors on vascular smooth muscle cells of microvessels is important in clarifying these mechanisms. a-Adrenergic receptors are known to exist as two distinct subtypes, a,-and a 2 -adrenoceptors, based on the relative affinity and potency of a series of agonists and antagonists on effector tissues. 4 " 7 Although a 2 -adrenoceptors were originally believed to be localized on adrenergic nerve endings, subsequent studies have reported the existence of postjunctional a 2 -adrenoceptors that mediate constriction of vascular smooth muscle with pump-perfused tissues or pithed rat preparations. 8 " 10 Recent in vivo and in vitro studies of whole tissue and isolated arteries and veins have verified these findings. However, an apparent paradox has arisen concerning the location of postjunctional vascular a 2 -adrenoceptors. 5 - 6 Studies of whole animal or perfused tissues have demonstrated their relative contribution to adrenergic constriction of regional vasculatures. However, in vitro studies of large arteries supplying the same tissues have been largely unsuccessful in demonstrating the existence of postjunctional a 2 -receptors, although a.-receptors are generally present. In contrast, in many veins studied in vitro a 2 -mediated contractile events are present and often more prominent than a, responses. Among several hypotheses advanced to reconcile this paradox, it has been suggested that postjunctional a 2 -adrenoceptors may be confined to smaller resistance vessels (arterioles) in the microcirculation. 5 -6 In this regard, recent studies suggest that a 2 -adrenoceptors may be more prominent on small than on large arteries. " l 2 However, to date no studies have examined the distribution of a-adrenoceptor subtypes on arterioles or venules in the microcirculation.
Therefore, the objectives of this study were to 1) determine whether microvessels possess postjunctional a 2 -as well as a,-adrenergic receptors, and 2) to determine whether the relative contribution of a,-and a 2 -receptors to adrenergic constriction varies among the three major anatomical and functional vessel levels (excepting the capillary bed) of the microcirculation, namely, the large distributing arterioles, terminal or precapillary arterioles, and capacitance venules. 2 For this purpose, the in situ cremaster muscle with intact, blood-perfused circulation was suspended in a controlled tissue bath, and vessel diameter was measured by intravital microscopy. Concentration-response relations were obtained by local application to the bath of selective adrenergic agonists and antagonists. The results suggest that adrenergic regulation of distinct levels within the skeletal muscle microcirculation may be predominantly subserved by different postjunctional a-adrenergic receptor subtypes.
Materials and Methods

Surgical Procedures
Seventy-one male, 6-7-week-old Sprague-Dawley rats (mean weight ± SEM, 171 ± 3 g) were anesthetized with urethane and a-chloralose (425 and 100 mg/kg i.p., respectively). Animals were given supplemental anesthesia (20-40% of initial dose) approximately 170 minutes after the initial administration and at approximately 70-minute intervals thereafter. Anesthetic supplements were given during holding and "wash" (see below) periods at least 10 minutes before the start of a control period. This regimen provided light surgical anesthesia, as judged by the presence of a weak, forepaw pinch withdrawal reflex. Rectal temperature was monitored continuously and maintained at 37 ± 0.5° C throughout the surgery and experiment with conducted and/or radiant heat. Animals breathed room air spontaneously via tracheostomy. The left carotid artery was cannulated for measurement of mean arterial pressure and heart rate, which were displayed on an oscillograph (Gould, Inc., Cleveland, Ohio) and recorded at 5-minute intervals. For all animals, the mean arterial pressure and heart rate at the beginning of the 3-3.5-hour experiments were (mean±SD) 108 ±12 mm Hg and 468 ±39 beats/min; at the end of the experiments, values were 102 ±10 mm Hg and 467 ±31 beats/min. Regression analysis indicated no significant change in these measurements over the duration of the experiments.
The right cremaster muscle (approximately 20 mm in diameter), an extension of the internal oblique and transverse abdominus muscles that surround the testicle, was prepared for in situ microvascular observation as described in detail elsewhere. 13 The muscle with intact circulation was suspended with 5.0 silk sutures over an optical port in a 40-ml tissue bath. The bath was filled from a stock reservoir containing a modified Krebs solution (280-290 mosm, 34 ±0.5° C) that consisted of (in mM) 25 ) were continuously monitored via indwelling probes, and Po 2 was periodically measured during each experiment via an oxygen macroelectrode and analyzer (IL 113, Allied Instrumention Lab., Lexington, Mass.).
The preparation was placed on the stage of a trinocular microscope (Nikon IC, modified), and the cremaster was transilluminated. The microcirculation was viewed through a 10 X Nikon water immersion objective (0.22 na), and the image was displayed on a closed-circuit camera (Cohu 4415 Sunnyvale, Calif.) and stored on videotape (Sony 2600). Vessel diameter (inner wall caliber) was measured with a video dimension analyzer (Vista 307) or custom electronic caliper 13 from the screen of a monitor (Sony C VM 131) that was calibrated in microns at the end of each experiment with a stage micrometer. The analog outputs of the video dimension analyzer and caliper were directed to the oscillograph; these signals were recorded simultaneously in direct and electonically averaged modes to provide a record of instantaneous and average vessel diameter. The video microscopic measurement system was accurate to ± 1 /im. Total magnification of the system varied from 400-1,220 x with a zoom projection lens (Nikon) to provide an optimal vessel image. A time reference (accurate to 0.01 seconds) was recorded on each video field. In some experiments, a green filter (VG-4 or VG-9) was positioned in the illumination axis to enhance microvessel contrast with the surrounding tissue.
The right cremaster muscle was acutely denervated following carotid artery cannulation by transecting via abdominal approach the right lateral cutaneous, iliohypogastric, ilioinguinal, and genitofemoral nerves. Previous studies have demonstrated that a denervation less extensive than this produced complete cremaster denervation. 15 In accordance with standard in vitro analysis of vascular smooth muscle, 16~" the Krebs solution at al 1 times contained propranolol (10 " 6 M) for blockade of y3-adrenergic receptors, and cocaine (4xlO~6 M), and normetanephrine (10" 3 M) for blockade of neuronal and nonneuronal uptake, respectively. Drug concentrations given here and elsewhere represent the final bath concentration. Approximately 30 minutes were allowed to pass after extension of the cremaster into the tissue bath to allow for equilibration. The preparation was examined prior to the start of the protocol and judged to be acceptable if 1) mean arterial pressure and heart rate were stable, and blood pressure was ^80 mm Hg, 2) terminal arterioles in the area of study exhibited vasomotion (spontaneous rhythmic cycles of constriction and dilation at 5-50 cycles/min), and 3) no venous stasis, leukocyte adhesion, or petechial hemorrhages existed in the area of study. If any of these criteria were not met during later control periods in an experiment, the protocol was interrupted until they became reestablished, or the experiment was terminated.
Experimental Protocol
Experiment 1: Effect of adrenergic agonists and antagonists on large arterioles and venules. In each experiment, micro vascular measurements were made on either a first-or second-order arteriole and its paired venule. Only 1 vessel pair was studied in each animal. First-order arterioles (mean±SEM diameter, 124 ±4 /xm; n = 26) and venules (179 ± 6 /xm, n = 26), which represent the largest paired, central cremasteric arteriole and venule, were observed approximately 0.5-1.0 cm beyond their point of entrance into the bathed cremaster. Second-order arterioles (72 ± 4 /im, n = 29) and venules (120 ± 7 /urn, n = 29) consisted of the first vessel pair to bifurcate to the right from the central vessel pair and were observed approximately 0.3-0.7 cm beyond their point of bifurcation.
Concentration-response curves for first-and secondorder arterioles and venules were constructed by stepwise, cumulative addition of norepinephrine (NE) to the cremaster bath. The concentration was increased in approximately half-log increments every 5 minutes after the response to the previous concentration had reached a steady-state, maximal response ( Figure 1 ; van Rossum"). Preliminary studies indicated, and present studies confirmed, that 5-minute intervals were sufficient to obtain the maximal response to a given concentration of agonist when agonists were applied in approximately half-log increments starting from or below threshold concentrations. Responses reached steady state at the latest by 2-3 minutes after application of agents ( Figure 1 ). Preliminary experiments indicated that a longer period (approximately 3-6 minutes) was sometimes required for vessels to reach a steady-state, maximal response after antagonist treatment or when agonists were applied after a control (i.e., no drug) period at concentrations that produced intermediate-to-high levels of constriction. Thus, in these instances a longer interval (10 minutes) of drug incubation was observed (see below). These intervals required to reach steady-state, maximal responses are dependent primarily on the time required for smooth muscle contraction, rather than on diffusion of drug molecules from the cremaster-bath interface to receptors on the embedded microvessels. The cremaster muscle is approximately 200-300 fim at its thickest point, which coincides with the region in which microvessels were measured in this study. Based on diffusion equations derived by Crank 20 and applied to diffusion of isoproterenol into cat papillary muscle, 2 ' complete diffusion of agents used in this study to vessels farthest from either cremaster surface would occur within 30-60 seconds.
After completion of the first concentration-response curve, the cremaster bath was changed 3 times during 10 minutes to ensure clearance of drugs from the tissue. Fifteen to twenty additional minutes were allowed to pass so that vessels could return from generally a dilated state after washing to control diameters. The total 25-30-minute interval between drug administration is subsequently referred to as a "wash" period. Supplemental anesthesia was given only during wash periods and at least 10 minutes before the start of a measurement period. After a second control period (Cj), the selective, competitive a 2 -receptor antagonist yohimbine or the a,-receptor antagonist prazosin 387 was added to the bath (lO" 8 ,10" 7 , 3 x 10" 7 , or 10" 6 M, 1 concentration per experiment), and the response was observed for 10 minutes. Subsequently, a second norepinephrine concentration-response curve (CRC 2 , Figure 1 ) was obtained as before in the presence of antagonist. Total time of exposure to an antagonist was 45 minutes. The presence or absence of a particular antagonist in the bath during the first versus second concentration-response curve was randomized. The antagonist and NE were removed from the tissue during a second 25-30- obtained to determine whether any alteration in preparation sensitivity had occurred over time. Thereafter, the bath was changed twice over 5 minutes, and nitroprusside was added to the bath (3 X 10~5 M) to achieve maximal smooth muscle relaxation. ' 3 After the modest, hypotensive effect of absorbed nitroprusside (lasting 1-2 minutes) was no longer evident, maximal vessel diameter was obtained during a 5-minute measurement period.
In a separate animal group (n = 4), control experiments were conducted to determine the stability of the preparation and adrenergic sensitivity over the 3-3.5-hour duration of the protocol examined in the above studies. The protocol for this experiment was identical to the above protocol with the exception that the cremaster was exposed to only the vehicle for the antagonists, rather than to yohimbine or prazosin themselves. A total of 4 arteriolar and venular pairs (2 first-and 2 second-order pairs) were studied.
In additional animal groups, cumulative concentration-response curves were determined in each animal for the selective a,-agonist phenylephrine 78 in the presence and absence of yohimbine (10~7 M) and in diflFerent animals for the a^-agonist B-WT933 1 -n - 23 inthe presence and absence of prazosin (10~8 M). The concentration-response curves were constructed identically to the above NE protocol. Only one agonist and antagonist were tested in each animal, and the presence or absence of the antagonist during the first versus second concentration-response curve was randomized. After the third control period, responses to a high NE concentration (3 x 10~6 M) added to the bath for 10 minutes were obtained for normalization of prior responses. Preliminary experiments indicated that in the absence of antagonist, NE concentrations in excess of this concentration do not produce greater constriction, regardless of whether exposure to an antagonist occurred earlier in the experiment. Maximal diameters were obtained as above during nitroprusside treatment at the conclusion of each experiment.
In each experiment, no more than 7 agonist concentrations were tested during generation of each of the two concentration-response curves, because additional concentrations would have extended the duration of the experiments beyond 3-3.5 hours. From our past experience, vascular responsiveness variably declines when protocols exceed this duration. Thus, the range of NE concentrations to be tested was shifted to the right in the presence of higher concentrations of antagonists; in some cases, however, maximal responses in the presence of high antagonist concentrations could not be achieved.
Experiment 2: Effect of antagonists on small arterioles. Twelve animals were studied for the effect on small (third-order, n = 6) versus large (first-and second-order, n = 6) arterioles of stepwise, cumulative addition of yohimbine and prazosin to the cremaster bath. Only one arteriole was studied in each animal. Arterioles that branched from second-order arterioles were designated as third-order arterioles (mean diameter, 25 ± 3 /im) and were studied approximately 150-500 /im from their point of bifurcation. These arterioles exhibited spontaneous vasomotion during control and agonist/antagonist treatments. The instantaneous and mean diameters for a third-order arteriole were obtained by continuous measurement of vessel diameter for 20-second intervals. After a 5-minute control period, NE was added to the tissue bath (10~8 M for third-order arterioles; 3 X 10~8 M for first-and second-order arterioles) to produce a moderate amount (20-30%) of NE constriction. Preliminary experiments indicated that intermediate levels of NE, phenylephrine, and B-HT 933 constriction are maintained for at least 40 minutes and that the magnitude of responses remains reproducible up to 3-3.5 hours. Ten minutes later, yohimbine was added (10~8 M) and increased in tenfold increments in two subsequent 10-minute intervals. After a 25-30-minute wash period and return to control diameter, NE was again added as above, followed by three 10-minute intervals of exposure to prazosin (10"', 10" 7 , and 3x 10~7 M). The order of administration of yohimbine versus prazosin was randomized among experiments. After a second 25-30-minute wash period, NE in the same concentration as the preceding test interval was applied for a final 10-minute interval to allow detection of any change in adrenergic sensitivity during the experiment. The bath was changed and nitroprusside added to obtain maximal arteriolar diameter.
Data Analysis
In all experiments except during wash periods, vessel diameters were obtained at 1-minute intervals either on-line or during off-line analysis of videotape. Values reported for diameters during control periods (no drug) represent averages of 5 measurements taken at 1-minute intervals over 5 minutes. Values reported for agonist and antagonist responses represent averages of 2 measurements taken at 1 -minute intervals during the last 2-minute interval prior to a change in bath drug concentration. For construction of concentrationresponse curves (Experiment 1), agonist responses are expressed as a percent of the maximal response to NE in the absence of antagonist:
where D c is the control diameter (in the absence or presence of antagonist), D, is the diameter produced by x concentration of agonist, and D,^ is the diameter obtained during maximal constriction with NE (3x 10" 6 M) in the absence of antagonist. Data were analyzed with paired and grouped t tests where appropriate. Analysis of variance and the DunnBonferroni procedure for paired comparisons were used when data were compared among more than two groups. Least-squares linear regression analysis was performed on blood pressure and heart rate data. Negative log concentration-response data were made linear by double reciprocal transformation of the data." Based on the observed normal distribution of log concentrations, 24 the apparent pD 2 values (pD 2 = -log EDJO; ED^,, concentration of the agonist needed to produce 50% of the maximal response) were calculated as a measure of the sensitivity to the agonist. 23 The EDj,, and slope at the ED*, value were derived from linear regression of double reciprocol plots of the concentration-response data. The apparent equilibrium dissociation constants (K B ) for prazosin and yohimbine (expressed as pK B = -log K B ) were obtained according to the following equation 16 :
where [B] is the concentration of the antagonist. The concentration ratio was derived from the ED*, ratio of norepinephrine in the presence and absence of antagonist. Results are expressed as the mean ± SEM, with /?<0.05 representing the level of significance.
Drugs
All agonists were prepared fresh daily in 10~3 M ascorbate saline. a-Antagonists were frozen in ascorbate saline for ^6 weeks and diluted on the day of the experiment. Propranolol hydrochloride, cocaine hydrochloride, and nitroprusside were dissolved in saline, and normetanephrine bitartrate in ascorbate saline (all from Sigma Chemical Co., St. Louis, Mo.); aliquots were frozen <6 weeks and thawed on the day of the experiment. All drugs were kept on ice in a dark container throughout the experiment. Drugs were added to the 40-ml cremaster bath as 36-40-/xl aliquots. The maximal cumulative concentration of ascorbate in the bath (8 x 10~6 M) had no effect on control vessel diameter or responses to NE. Preliminary studies with the catecholamines and B-HT 933 indicated that the ascorbate added to the cremaster bath with drug aliquots was sufficient to prevent breakdown (i.e., responses were maintained) over the 35-minute exposure periods in these studies. Prazosin hydrochloride was a gift of Pfizer Inc., Groton, Conn., and B-HT 933 was kindly donated by Thomae GMBH, Biberach an der Riss, FRG. Norepinephrine hydrochloride, phenylephrine hydrochloride, and yohimbine hydrochloride were obtained from Sigma Chemical Co.
Results
Responses of Large Arterioles and Venules to Norepinephrine and a-Adrenoceptor Antagonists
Control experiments. Figure 1 shows results from a representative experiment that examined the effect of selective a-adrenergic receptor antagonists on norepinephrine (NE)-induced arteriolar constriction (see "Materials and Methods" for details). Control experiments, identical to this protocol but without addition of antagonists, were conducted in which the sensitivity of arterioles and venules to NE were evaluated over the 3-3.5-hour duration of the protocols used in the present studies. This was done to validate the analysis of sequential concentration-response curves and to confirm that the effect of the antagonists were reversed by the 25-30-minute wash periods. Baseline diameters of arterioles and venules during the three successive control periods (C,, Q, and C 3 ) did not differ and were significantly smaller than diameters produced by nitroprusside (Table 1 ). There was no difference in the two successive NE concentration-response curves irrespective of time for both arterioles and venules, and the vessel groups were thus combined ( Figure 2 ). When tested at the conclusion of the protocol with an intermediate concentration of NE, both arterioles and venules constricted to diameters that did not differ from those obtained with exposure to the same concentration during the two earlier concentrationresponse curves (Table 1) . Thus, baseline tone and adrenergic responsiveness were constant over the duration of the experiments.
In the subsequent antagonist studies, evaluations similar to those above were made to monitor the stability and sensitivity of the preparation. During both the yohimbine and prazosin experiments, arteriolar and venular diameters during successive control periods did not change significantly (Figures 1 and 3 ). This indicates that basal smooth muscle tone was maintained relatively constant over the duration of the experiments. The amount of basal (control) tone was revealed by nitroprusside-induced maximal dilation (Figure 3 ). Relative to the average diameter during the three control periods, nitroprusside dilated arterioles in the yohimbine and prazosin groups by 29 and 27% of control, respectively. Nitroprusside dilated venules in the yohimbine and prazosin groups by smaller amounts, 10 and 9%, respectively. Therefore, control diameters and tone were similar for the yohimbine and prazosin groups and comparable to values obtained in the experiments performed in the absence of antagonists (Table 1) . Constrictor responses to an intermediate concentration of NE given at the end of the yohimbine and prazosin experiments were similar to 
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Control experiments with 2 successive NE concentration-response curves (CRCs) in absence of adrenergic antagonists (see Figure 1 for design).
C(, C 2 , and C 3 are average diameters prior to first and second CRC and prior to final exposure to a single concentration of NE, respectively. NE,, NE2, and NE 3 are diameters produced by intermediate concentration of NE applied during first and second CRC and during final NE exposure, respectively. *p<0.07, tp<0.025 vs. C 3 . Values expressed as mean ± SEM diameter (microns). Figure  1) responses for the same concentration obtained 1-2 hours earlier in the experiments in all but 1 group of venules ( Figure 4 ). Taken together with the data in Figures 2 and 3 and Table 1 , it is evident that adrenergic reactivity was fully sustained in arterioles, but venules variably exhibited reduced responsiveness. Because the experimental design randomized the two concentrationresponse curves for the presence or absence of antagonist, any changes in venular smooth muscle responsiveness did not influence subsequent analyses.
Antagonist studies. The effect of yohimbine and prazosin on the NE concentration-response relation for arterioles and venules is shown in Figure 5 and Table  2 . Yohimbine produced concentration-dependent, rightward shifts in the NE concentration-response relation for arterioles and venules at concentrations of 10~7 and 10"' M, with the venules tending to exhibit greater displacement at lower NE levels ( Figure 5 ). Norepinephrine pD 2 values were significantly lower at 10" 7 and 10~6 M yohimbine for both vessel types (Table  2) . Maximal responses were unaffected by yohimbine, but the slope was reduced for the arterioles at 10~6 M and increased for the venules at 10~7 and 10~6 M ( Table  2) . Prazosin also produced concentration-dependent, rightward shifts in the NE concentration-response curves for arterioles and venules at all concentrations tested. As with yohimbine, venules exhibited greater overall displacement by prazosin than arterioles ( Figure 5 ). In contrast with yohimbine, dextral displacement by prazosin tended to be greater at higher levels of NE for both vessel types, especially the venules. Although not shown, higher concentrations of NE (1 and 3 x 10~4 M) that were tested in some animals in the presence of 3 x 10~6 M prazosin produced additional constriction. Higher concentrations of prazosin reduced the slope of the NE relation for both arterioles and venules.
Effects of yohimbine and prazosin on control diameters prior to exposure to NE are shown in Figure 6 .
Yohimbine alone increased arteriolar diameter only at the highest concentration. Prazosin alone modestly increased arteriolar diameter at all concentrations. Resting venular diameter was unaffected by either antagonist.
Responses of Large Arterioles and Venules to Selective a-Adrenoceptor Agonists
Phenylephrine in the presence and absence of yohimbine, and B-HT 933 in the presence and absence of prazosin were evaluated to determine, using order of agonist potency, whether both a,-and o^-adrenoceptors are present on microvessels and to determine the selectivity of the antagonists for either receptor subtype (Figure 7) . Phenylephrine produced concentrationdependent arteriolar and venular constriction that was unaffected by yohimbine at the lowest concentration (10~7 M) that significantly antagonized NE responses in the antagonist experiments. Similarly, B-HT 933 produced concentration-dependent constriction (10"' M) that produced significant antagonism of NE responses in the antagonist experiments.
The sensitivity (pDj) of arterioles and venules to phenylephrine and B-HT 933 was significantly less than to NE (Table 3 ). The order of potency for both vessel types was NE > phenylephrine > B-HT 933. Relative to NE and phenylephrine, B-HT 933 produced significantly smaller "maximal responses" for arterioles and venules (Table 3 ). Thus, it should be emphasized that quantitative comparisons of B-HT 933 potency with NE and phenylephrine are approximate because the B-HT maximal responses were lower than NE and phenylephrine maximal responses. Sensitivity to NE and phenylephrine was greater for arterioles than 
FIGURE 3. Control diameter in microns (C,, C } , and Cj) during the yohimbine and prazosin experiments for protocol shown in Figure 1. Maximal diameter indicated by response to nitroprusside (NP). Values are mean±SEM, n, number of vessels (animals). Significance by ANOVA and Bonferroni.
TEST DOSE OF NOREPINEPHRINE GIVEN AT BEGINNING (NE,) AND END (NE 2 ) OF EXPERIMENT
FIGURE 4. Response of microvessels to an intermediate test dose of norepinephrine given at the end of yohimbine and prazosin experiments (NE 2 ) versus beginning of experiments in absence of antagonist (NE,) for protocol shown in Figure 1. Values are mean±SEM; n, number of vessels (animals) normalized to the maximal response to high concentration ofNE (3 x 10' 6 M). The average test dose of norepinephrine (in moles) for the yohimbine experiments was 7.49 x 10-'±1.38x J0~'; the average dose for the prazosin experiments was 1.49X 10~7±6.33 X 10~'. Significance by paired t test.
venules, but the sensitivity of both vessel types to B-HT 933 was similar (Table 3) . Slopes for the arteriolar responses to the three agonists were similar. However, arteriolar slope for NE was significantly lower than the venular slope, and a similar trend was evident for phenylephrine ( Table 3 ). The slope of the venular B-HT 933 relation was significantly lower than venular slopes for NE and phenylephrine.
In the large vessel studies, approximately equal numbers of first-and second-order arterioles and venules were studied in all experimental groups.
Norepinephrine sensitivity (pDJ for first-and secondorder arterioles did not differ significantly (7.21 ± 0.11 versus 7.53 ±0.20) nor did the sensitivity of first-and second-order venules (7.05 ±0.07 versus 7.23±0.01). Thus, first-and second-order vessels were combined in all analyses. However, the wellknown inverse relation between microvessel diameter and NE sensitivity was evident as a trend in these data. Arteriolar constriction decreases "downstream" venular intravascular pressure. Therefore, reductions in venular diameter could partially represent passive responses to arteriolar constriction. To examine this possibility, a group of experiments was performed in which vasopressin was administered for a 10-minute interval at the end of the experiment prior to nitroprusside treatment. In preliminary experiments, we had observed that vasopressin was a potent arteriolar constrictor, producing maximal arteriolar constriction at 2 mlU/ml bath concentration but had no effect on venular diameter. This effect is clearly evident in Figure  8 . Arterioles and venules evidenced respective constriction of 61 and 56% in response to a maximal concentration of NE (3 x 10~6 M) ( Figure 8 ). However, though arterioles exhibited a similar maximal constriction to vasopressin, venular diameter was unaffected by the peptide.
Because successive concentrations of yohimbine and prazosin produced nonparallel, dextral displacement of NE concentration-response curves, pA 2 calculation by Schild analysis was not possible. Instead, the apparent dissociation constant (K,,, expressed as pK B = -log K B ) for antagonism of NE constriction of large arterioles by prazosin (10~8 M) and yohimbine (10~7 M) was calculated according to the method of Furchgott." These antagonist concentrations were shown to be selective for a,-and a 2 -adrenoceptors, respectively ( Figure 7 ) and caused parallel dextral displacement of arteriolar NE concentration-response curves ( Figure 5 and Table 2 ). pK B values for prazosin and yohimbine were 7.83 + 0.65 and 7.36 + 0.46, respectively. Because venular response curves were not shifted in a parallel manner by these antagonist concentrations Data derived from regression analysis of reciprocol plots of concentration-response data (see "Materials and Methods") and are presented as pD 2 ( -log EDJQ), slope, and Max Resp = maximal response as a percent of response to norepinephrine, 3 x 10" 6 M, during control. *p<0.05; tp<0.01 relative to control (paired nest). Values are mean ±SEM;n, number of vessels (animals). Values of pD 2 and slope for PRZ's action on venules at & 10~8 M and on arterioles at 3 x 10~7 M were calculated after linear extension of the respective curves (Figure 4 ) to 100% (see "Results"). YOH, yohimbine; PRZ, prazosin. Figure 6 ).
Values are mean±SEM, n, number of vessels (animals).
( Figure 5 and Table 2 ), venular pK B values could not be calculated.
Effect of a-Adrenoceptor Antagonists on Small Versus Large Arterioles
Responses of small, third-order arterioles versus large first-and second-order arterioles to progressively increasing concentrations of yohimbine and prazosin were studied in separate groups of animals to determine whether adrenergic-induced arteriolar tone of large versus small arterioles depended to differing degrees on Oj-and a,-adrenergic receptors. Venules were not compared in these studies because most third-order venules are devoid of smooth muscle.
2 -3 An intermediate level of vasoconstriction was produced in small arterioles by addition of NE to the cremaster bath. This constriction was significantly attenuated in a concentration-dependent manner by yohimbine ( Figure 9 ). In contrast, prazosin only significantly attenuated NEinduced constriction of small arterioles at the highest concentration (3 X 10~7 M). Norepinephrine constriction of large arterioles, on the other hand, was significantly attenuated in a concentration-dependent manner by both yohimbine and prazosin ( Figure 9 ).
hi agreement with baseline data in the previous protocol, control diameters during the experiment were not different nor were responses to NE (Figure 9) . Maxima] dilation by nitroprusside indicated that resting tone during control periods was much greater for small versus large arterioles in terms of both absolute and percent of control diameters.
Discussion
The major findings of this study were that successively increasing concentrations of the competitive a,-and Oj-antagonists prazosin and yohimbine, respectively, produced nonparallel, dextral displacement of norepinephrine concentration-response curves for large arterioles and venules. Significant parallel displacement occurred at low antagonist concentrations demonstrated to be selective for the respective receptor subtypes. The selective agonists phenylephrine (a,) and B-HT 933 (aj evoked concentration-dependent constrictions of both vessel types that were unaffected by low concentrations of yohimbine and prazosin, respectively. "Maximal" constriction of arterioles and venules to B-HT 933 appeared to be substantially less than that produced by norepinephrine or phenyleph- rine, as was the apparent sensitivity ( -log pDJ to B-HT 933. Calculation of apparent equilibrium dissociation constants for prazosin and yohimbine yielded values consistent with interaction of the antagonists with a,-and a 2 -adrenoceptors, respectively (see below). These data argue that both receptor types mediate NE-induced constriction of large arterioles and venules. However, in contrast to large micro vessels, NE constriction of small precapillary arterioles was unaffected by low, subtype-selective concentrations of prazosin but was reduced in a concentrationdependent manner with yohimbine. The data suggest that adrenergic regulation of large arterioles and venules in skeletal muscle uses both a r and o^-adrenoceptors. Precapillary arterioles, however, may be subserved predominantly by a 2 -receptors. An important assumption of the present study is that a 25-30-minute wash period was sufficient to remove the antagonists from the tissue. Several observations validate this assumption (in addition to the short diffusion time predicted for the cremaster preparation [see "Materials and Methods"]). 1) The control experiments, conducted in the absence of antagonists, demonstrate that baseline tone (control diameter, Table  1 ) remained unchanged during the protocol. Control diameters during the antagonist experiments were similarly constant (Figures 3 and 9) . The presence of antagonist during the first versus second concentrationresponse curve was randomized. If the wash periods after the first and second concentration-response curves were insufficient to wash out antagonists, then control diameters during Q and C 3 should have been greater than during C, (Figures 3 and 9 ) because large vessels appear to possess adrenergic tone during control ( Figure 6 ). 2) The control experiments also demonstrate that NE sensitivity remained constant over the experimental duration (Table 1 and Figure 2 ). If reversal of adrenergic blockade was not achieved by the wash periods in the antagonist studies, then responses to intermediate NE concentrations, when tested at the end of the experiments, should have been less than responses obtained earlier in the experiments; instead, they were unchanged (Figures 4 and 9) . 3) Also, the arteriolar and venular responses to the NE test doses (Figure 4) , when plotted on the graphs in Figure 5 , fall on the control curves for the yohimbine experiments and are to the right of the control curves by insignificant amounts (0.05 and 0.15 log units for the arterioles and venules, respectively) for the prazosin experiments. In addition, the control curves in Figure 5 represent NE responses obtained either during the first or second concentration-response curve, before or after obtaining the curve in the presence of antagonist (because presence of antagonist during the first versus second concentration-response curve was randomized). If reversal of antagonism was not achieved during the wash periods, then the control curves in Figure 5 should lie to the right of the curves obtained in experiments without antagonist treatment ( Figure 2) . Comparison of the curves and pD 2 values (See Table 3 and legend for Figure 2 ) demonstrates that this is not the case. The negative logarithms of the antagonist equilibrium dissociation constants (apparent K B ) for prazosin versus norepinephrine and yohimbine versus norepinephrine calculated from the dose-ratio method of Furchgott 16 were 7.83 and 7.36, respectively, for constriction of large arterioles (Table 4) . These values are in general agreement with published values ob- *pK B , -l o g K B (dissociation constant derived from the doseratio method of Furchgott [ 1972] in present microcirculation experiments; derived from Shield analysis (pA^ in the cited studies). tFor rat cremaster arterioles the mean ± SEM pK B values for prazosin and yohimbine are 7.83±0.65 (n = 4) and 7.36±0.46 (/i=ll), respectively. ^Against the a^-agonist, cirazoline.
tained from Schild analysis (pA 2 values, pA 2 = -log K B ) of prazosin and yohimbine antagonism of norepinephrine contraction in in vitro studies of vascular smooth muscle of large arteries and veins supplying skeletal muscle (Table 4 ). This suggests that norepinephrine constricts arterioles (and presumably venules) by activation of a,-and a 2 -postjunctional adrenergic receptors that are pharmacologically similar to those found in large arteries and veins. However, this conclusion is made cautiously because norepinephrine is a nonselective agonist of these receptors with almost coincident concentration-response curves at each receptor type, 26 and because yohimbine has low selectivity relative to prazosin. Also, there is a very wide range of pA 2 values that have been obtained for the interaction of yohimbine and prazosin with a-adrenoceptors. 26 - 27 Indeed, in vascular smooth muscle from arteries that do not supply skeletal muscle and in some nonvascular smooth muscles, pA 2 values for yohimbine range from approximately 5.4 to 7.7, and pA 2 values for prazosin are generally greater than in the present study, ranging from 7.9 to 11.0 (cf., Drew, 27 Flavahan and Vanhoutte
26
). Prazosin and yohimbine are well-characterized, competitive antagonists of a-adrenoceptors, with prazosin exhibiting a selectivity for a,-adrenoceptors (over a j of greater than 100 times and with yohimbine a selectivity of greater than 10-50 times for the a 2 -receptor. 7 In the present study, the significant, competitive antagonism of norepinephrine responses of large arterioles and venules by prazosin and yohimbine at 10"* and 10~7 M, respectively ( Figure 5 ), can be attributed to the specificity of these concentrations for a,-and a 2 -receptors, respectively. This was demonstrated by the lack of effect of prazosin at 10" 8 M on the B-HT 933 response curve and the lack of effect of yohimbine at 10~7 M on the phenylephrine response curve (Figure 7) . The latter data also suggest that phenylephrine and B-HT 933 produced constriction by specific action at a,-and a 2 -receptors, respectively. These data and the good agreement of our apparent K B values for prazosin and yohimbine with literature values for arteries and veins supplying skeletal muscle ( Table 4 ) provide evidence that arterioles and venules possess both adrenergic receptor subtypes. This conclusion is further supported by the observation that higher concentrations of these selective antagonists, known to be reversible and competitive over the concentrations used in this study, produced nonparallel, dextral displacement of norepinephrine concentration-response curves ( Figure 5 and Table 2 ). This nonparallel displacement at higher concentrations is consistent with an action of norepinephrine on more than one receptor type. 21 Prazosin caused greater displacement at high norepinephrine concentrations and yohimbine at low norepinephrine concentrations, particularly for the venules. This suggests that norepinephrine may act primarily at a relatively prazosin-resistant site (i.e., the Oj-receptor) at low concentrations, with progressive interaction at a yohimbine-resistant site (i.e., the a,-receptor) at higher norepinephrine concentrations. Similar findings were obtained in canine saphenous vein, leading to the conclusion that both receptor types were present in this vessel.
2SJ9M Several groups (Drew and Whiting* and Grega and Adamski 33 ) have found evidence for both receptors mediating constriction of the perfused hind limb vasculature.
Although the interpretation of the nonlinear dextral displacement of norepinephrine curves by prazosin and yohimbine in support of the existence of both a,-and c^-adrenoceptors is consistent with our results with selective agonists and similar interpretations of others,"•' SM other mechanisms can produce such nonlinearities." However, disturbances in linearity produced by the action of catecholamine uptake processes, /3-adrenoceptors, and alterations in transmitter release were prevented by pharmacologic and surgical interruption of these processes. Inadequate antagonist equilibration times can also produce nonlinearities. However, in preliminary studies and subsequently supported in the experiments, both yohimbine and prazosin increased arteriolar diameters to maximal, steady-state values within 5 minutes after application, and an additional 5 minutes was observed prior to application of the first (usually subthreshold) concentration of norepinephrine. This rapid equilibration is consistent with the short, 30-60-second diffusion time estimated for the thin cremaster (see "Materials and Methods").
Responses of microvessels were obtained for bathadded agonists that diffused through the thin cremaster and across the microvessel wall from adventitia to lumen. This methodological feature has several implications. It should be recognized that the steady-state concentration of agonist will vary across the vessel wall as a function of the rate of lumenal blood flow because of diffusion into the bloodstream. The magnitude of this diffusional "sink" would remain constant at constant flow and would have the effect of lowering the actual ("true") concentration of ligand in the receptor biophase by some fixed amount relative to the bath concentration. However, progressive constriction of arterioles throughout the microvascular network at increasing bath concentration of agonist, by reducing blood flow, would tend to reduce the diffusional loss of ligand to the adjacent blood stream. Thus, at low bath agonist concentration and high flow, the responses that we actually obtained probably lie to the right of the true concentration-response relation. Progressively higher bath concentrations and lower flows would cause the obtained curves to rise more steeply and progressively shift to the left toward the true curve. Thus, the reported values for slopes are likely to be slightly greater than the true slope for the vascular smooth muscle, and true pD 2 values are likely to be somewhat greater than those reported.
Responses to bath administration of norepinephrine may differ from results obtained with nerve stimulation or administration of blood-borne norepinephrine. However, our data may approximate the response to adrenergic nerve stimulation where, like bath administration, norepinephrine released from the outer-wall neural plexus similarly diffuses across the vascular wall to the lumen. It has been reported that the sensitivity of in vitro vascular preparations to norepinephrine applied to the lumenal side is greater compared with adventitial application; however, the difference is eliminated after blockade of neuronal uptake by chemical destruction of the adrenergic plexus in the outer vascular wall. 36 In the present study, pharmacologic inhibition of neuronal uptake by cocaine would be expected to have a similar effect.
Small, precapillary or terminal arterioles were exposed to low-to-moderate levels of exogenous norepinephrine and subsequent antagonism with yohimbine or prazosin to evaluate a-receptor subtype contribution to the constriction. Yohimbine produced significant antagonism at a concentration (10~7 M) shown in the previous experiments on large microvessels to be specific for a r receptors and produced additional concentration-dependent dilation at higher concentrations. In contrast, prazosin had no effect at the concentration shown in the previous experiments (10" 8 M) to be specific for a,-receptors, or at a tenfold higher concentration. A modest dilation occurred only at the highest concentration tested (3 x 10~7 M) that may not be selective for the a,-receptor. By comparison, both antagonists produced similar concentration-dependent dilation of large arterioles at all concentrations tested. Based on these data, we postulate that large arterioles (and venules) are subserved by both postjunctional adrenergic receptor types, but adrenergic constriction of terminal arterioles may depend largely on a 2 -adrenoceptors. However, the clear difference in sensitivity to prazosin between large and small arterioles may reflect differences in the way that the a,-and Oj-adrenoceptors interact between these blood vessels, rather than reflecting differences in receptor density.
A limitation of studies of the intact microcirculation arises in evaluating responses to vasoactive agents applied to the whole bed for small arterioles or venules that are located downstream from large arterioles also affected by the agents. Changes in diameter of upstream vessels are likely to alter intravascular pressure and flow in downstream vessels. This could affect the resting vascular smooth muscle length-tension relation of dependent vessels and also alter local metabolic and myogenic mechanisms. Hence, the concentrationresponse relation of downstream vessels would likely be altered and would complicate analysis of the direct effects of the agents on die vessels. This remains a limitation of our small arteriolar studies. However, since large arterioles were dilated similarly by both yohimbine and prazosin (Figure 9 ), any alteration in downstream pressure or flow should be similar. Thus, it is less likely that the marked difference in small arteriolar responses to yohimbine and prazosin could be attributed to differences in local conditions. With a similar reasoning, it is evident from the effect of vasopressin to cause constriction of large arterioles but not venules that venular constriction to norepinephrine is not simply a passive response to simultaneous arteriolar constriction.
The differential effect of vasopressin on arterioles and venules in skeletal muscle contrasts with effects observed in the mesenteric microcirculation. In rat mesentery, maximal responses of large arterioles were elicited at concentrations comparable to those used in the present study. 3 However, venular sensitivity in that study exceeded that of arterioles by more than 100 times. Although the potency of vasopressin clearly varies among certain vascular beds, 3 the lack of any constrictor action on muscular venules in cremaster skeletal muscle is interesting. This finding is consistent with a weak action of vasopressin on mean circulatory filling pressure, an index of total body venous tone, compared with angiotensin and norepinephrine. 37 There is both in vitro and in vivo evidence that adrenergic constriction of venous smooth muscle may rely predominantly on a 2 -receptors. 29J7 In the latter study, infusions of the a,-adrenergic agonist methoxamine did not affect mean circulatory filling pressure, but norepinephrine and the selective a 2 -agonist B-HT 920 produced dose-dependent increases. 37 Thus, arteries and veins may differ with regard to a-receptor distribution, with a,-receptors predominating on arterial and a 2 -receptors on venous smooth muscle. Our data suggest that a-adrenoceptor subtypes on microvessels may have an additional distinct pattern of distribution as well.
hi the present studies, the cremaster was surgically denervated to eliminate nerve activity-related release of endogenous norepinephrine that could vary as a function of depth of anesthesia or via interaction of a-adrenergic ligands with presynaptic a-receptors. Thus, denervation minimized the possibility that release of norepinephrine would occur to complicate the analysis of microvessel responses to exogenous agonists and antagonists through alterations in concentration of agonist at postjunctional receptors. Prazosin alone produced concentration-dependent dilation of large arterioles but not venules ( Figure 6 ). Yohimbine alone only produced arteriolar dilation at the highest concentration, probably by an action at a,-receptors. These data indicate that large arterioles possessed resting adrenergic tone most probably due to an action of circulating catecholamines at primarily a,-receptors. In other studies of acutely denervated cremaster, we have found that large arterioles dilate by a similar amount in response to the nonselective a-adrenoceptor antagonist, phentolamine (10~6 M; J. Faber, unpublished results). In the acutely denervated skeletal muscle vasculature of the dog, adrenergic tone appears to be partially restored by circulating catecholamines. 38 The lower sensitivity of venules than of arterioles to norepinephrine may account for the absence of resting adrenergic tone in these vessels ( Figure 6 ).
In contrast to large arterioles, small arterioles exhibited considerably more basal (control) tone as estimated by the extent of dilation to nitroprusside ( Figure 9 ). However, small arteriolar diameter was not increased significantly over control values by even the highest concentrations of yohimbine or prazosin. Thus, unlike large arterioles, basal tone of small arterioles was not dependent on catecholamines but more likely depended on intrinsic myogenic and metabolic mechanisms known to account for a greater degree of resting tone in small arterioles. 239 Given our evidence for postjunctional a, dominance of small arterioles, the apparent greater affinity for norepinephrine for the Oj-adrenoceptor (see also Flavahan et al 28 ) and the well-known greater nonadrenergic sensitivity of small arterioles than of large arterioles (Rosell, 1 Renkin, 2 Altura, 3 note also the lower concentration of norepinephrine necessary to produce a similar percent constriction of small versus large arterioles in Figure 9 ), it would seem unexpected that large rather than small arterioles exhibited basal adrenergic tone. It is possible that, at least under the present experimental conditions, the large amount of tone presumably generated by intrinsic mechanisms in the small arterioles may lessen their sensitivity to low levels of circulating catecholamines.
hi conclusion, these studies provide the first quantitative characterization of a-adrenoceptors across different levels of the microcirculation. Norepinephrine-induced constriction of large arterioles and venules was mediated by both a,-and a 2 -postjunctional adrenergic receptors. Thus, in distinction to large arteries, vascular smooth muscle of large arterioles possesses both adrenergic receptors. In contrast to large arterioles and venules, constriction of terminal arterioles appeared to be mediated predominantly by c^-adrenoceptors. Whether similar differences are shared by microvessels of other tissues remains unknown. Moreover, whether postjunctional a-adrenoceptors subserve unique physiologic functions and confer, by their relative pattern of distribution, specialized regulatory features on different vascular levels are important unanswered questions. Both receptors may contribute to basal neurogenic tone and reflex control of regional vascular resistance. Hind limb vasoconstrictor responses to sympathetic stimulation in dog and cat are in part mediated by o^-adrenoceptors. 40 Studies of forearm blood flow in humans indicate that both postjunctional a,-and a 2 -receptors contribute to basal vascular tone. 41 Also, systemic blockade of a r receptors with prazosin only partially inhibited reflex cardiovascular responses to cold, carotid baroreceptor inhibition, and static and dynamic exercise.
4243
These data are consistent with the present finding of both receptors on large arterioles and venules-^micro-vascular segments of major importance in the neuralhumoral regulation of regional resistance and venous capacitance. 44 It is tempting to speculate that a possible predominance of postjunctional ctj-adrenoceptors on small, precapillary arterioles might be involved in prominent or unique regulatory features evident at this level of the microcirculation, such as vasomotion, escape from sympathetic stimulation, sensitivity to local tissue conditions and control of capillary perfusion. 2 It is also possible that differences in the dominant a-adrenoceptor subtype at different levels within the microcirculation may reflect differences in excitation-contraction coupling of vascular smooth muscle among the vessel levels.
